{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:04:40Z","timestamp":1791590680254,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","award":["2020-J-3"],"award-info":[{"award-number":["2020-J-3"]}],"id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","award":["2023-J-03"],"award-info":[{"award-number":["2023-J-03"]}],"id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","award":["23-A-22"],"award-info":[{"award-number":["23-A-22"]}],"id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","award":["26-A-4"],"award-info":[{"award-number":["26-A-4"]}],"id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","award":["29-A-3"],"award-info":[{"award-number":["29-A-3"]}],"id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP16ck0106079"],"award-info":[{"award-number":["JP16ck0106079"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17ck0106350"],"award-info":[{"award-number":["JP17ck0106350"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H26-076"],"award-info":[{"award-number":["H26-076"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ejso.2023.107324","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T21:27:34Z","timestamp":1703021254000},"page":"107324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8828-1067","authenticated-orcid":false,"given":"Shogo","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Nakachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4050-2086","authenticated-orcid":false,"given":"Masafumi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gakuto","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiichi","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6493-4732","authenticated-orcid":false,"given":"Hiroaki","family":"Yanagimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Nakagohri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2003-6110","authenticated-orcid":false,"given":"Yasuhiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Ajiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Gotohda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4480-0029","authenticated-orcid":false,"given":"Makoto","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-807X","authenticated-orcid":false,"given":"Takuji","family":"Okusaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Furuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2023.107324_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jhbp.314","article-title":"Biliary tract cancer registry in Japan from 2008 to 2013","volume":"23","author":"Ishihara","year":"2016","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"12","key":"10.1016\/j.ejso.2023.107324_bib2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/jjco\/hyaa170","article-title":"Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials","volume":"50","author":"Nara","year":"2020","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2023.107324_bib4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/bjs.10776","article-title":"Bile Duct Cancer Adjuvant Trial (BCAT) Study Group. Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer","volume":"105","author":"Ebata","year":"2018","journal-title":"Br J Surg"},{"issue":"8","key":"10.1016\/j.ejso.2023.107324_bib5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.18.00050","article-title":"Gemcitabine and Oxaliplatin chemotherapy or Surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study","volume":"37","author":"Edeline","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2023.107324_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2012.7352","volume":"308","author":"Neoptolemos","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ejso.2023.107324_bib3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2023.107324_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00534-011-0499-x","article-title":"Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction","volume":"19","author":"Konishi","year":"2012","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"4","key":"10.1016\/j.ejso.2023.107324_bib8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/jjco\/hyy004","article-title":"Hepatobiliary and pancreatic Oncology group of the Japan clinical Oncology group. A randomized phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan clinical Oncology group study (JCOG1202, ASCOT)","volume":"48","author":"Nakachi","year":"2018","journal-title":"Jpn J Clin Oncol"},{"issue":"10372","key":"10.1016\/j.ejso.2023.107324_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","article-title":"Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial","volume":"401","author":"Nakachi","year":"2023","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ejso.2023.107324_bib10","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00423-020-01955-3","article-title":"Invasion category-oriented lymph node metastases of cholangiocarcinoma and the prognostic impact","volume":"405","author":"Kobayashi","year":"2020","journal-title":"Langenbeck's Arch Surg"},{"issue":"1","key":"10.1016\/j.ejso.2023.107324_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10620-013-2894-4","article-title":"Prediction of the postoperative prognosis of intrahepatic cholangiocarcinoma (ICC): importance of preoperatively- determined anatomic invasion level and number of tumors","volume":"59","author":"Marubashi","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.ejso.2023.107324_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00280-014-2543-4","article-title":"Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study","volume":"74","author":"Kobayashi","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ejso.2023.107324_bib19","series-title":"International Union against Cancer. UICC TNM classification of malignant tumors","author":"Sobin","year":"2010"},{"key":"10.1016\/j.ejso.2023.107324_bib20","unstructured":"Japanese Society of Biliary Surgery. Classification of biliary tract carcinoma. Scond English Edition. Kanehara & Co., Ltd, Tokyo."},{"issue":"3","key":"10.1016\/j.ejso.2023.107324_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1365-182X(17)30755-4","article-title":"The Brisbane 2000 Terminology of liver anatomy and resections","volume":"2","author":"Belghiti","year":"2000","journal-title":"HPB"},{"issue":"12","key":"10.1016\/j.ejso.2023.107324_bib22","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/lt.21622","article-title":"Liver regeneration in donors and adult recipients after living donor liver transplantation","volume":"14","author":"Haga","year":"2008","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.ejso.2023.107324_bib23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/ajt.15627","article-title":"Long-term impact and clinical significance of living donor liver transplantation with respect to donor liver restoration and spleen size: a prospective study","volume":"20","author":"Yoshino","year":"2020","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ejso.2023.107324_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061769","article-title":"Donor safety in living donor liver transplantation: a single-center analysis of 300 cases","volume":"8","author":"Lei","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ejso.2023.107324_bib25","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/TP.0b013e3181ba184a","article-title":"Biliary reconstruction in living donor liver transplantation: technical invention and risk factor analysis for anastomotic stricture","volume":"88","author":"Marubashi","year":"2009","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ejso.2023.107324_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s002800050687","article-title":"Pharmacokinetics of adriamycin and cisplatin for anhepatic chemotherapy during liver transplantation","volume":"40","author":"Ku","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"10.1016\/j.ejso.2023.107324_bib18","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00280-013-2311-x","article-title":"Evaluation of safety parameters and changes in serum concentration in liver transplant recipients treated with doxorubicin during the anhepatic period","volume":"72","author":"Kobayashi","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"10.1016\/j.ejso.2023.107324_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00280-019-03969-1","article-title":"Pharmacokinetic and toxicodynamic evaluation of 5-fluorouracil administration after major hepatectomy in a rat model","volume":"85","author":"Tada","year":"2020","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"10.1016\/j.ejso.2023.107324_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/SLA.0000000000002865","article-title":"A\u00a0prospective, randomized phase II study of adjuvant gemcitabine versus S-1 after major hepatectomy for biliary tract cancer (KHBO 1208): Kansai Hepato-biliary Oncology group","volume":"270","author":"Kobayashi","year":"2019","journal-title":"Ann Surg"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323009629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323009629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:49:30Z","timestamp":1760060970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798323009629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0748798323009629"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2023.107324","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2023.107324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107324"}}